Caitong International Asset Management Co., LTD Veracyte, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Veracyte, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 205 shares of VCYT stock, worth $5,612. This represents 0.0% of its overall portfolio holdings.
Number of Shares
205
Previous 433
52.66%
Holding current value
$5,612
Previous $17.1 Million
64.55%
% of portfolio
0.0%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding VCYT
# of Institutions
306Shares Held
79.1MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$226 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$213 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$143 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.94MShares$108 Million1.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$105 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.96B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...